Ilsung Pharmaceuticals Co., Ltd. (KOSE:A003120) announces a share repurchase program. Under the program, the company will repurchase up to 53,200 shares. The program is aimed at stock price stability and shareholder value enhancement.

The repurchases will be valid till May 9, 2022. As of February 8, 2022, the company had 1,028,367 treasury shares within the range of dividends available and 97,865 treasury shares under other repurchases.